pI: 4.729 |
Length (AA): 373 |
MW (Da): 43190 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 5 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1 | 373 | 4cfh (A) | 13 | 419 | 22.00 | 0 | 1 | 1.1172 | 0.73 |
2 | 361 | 4fr4 (A) | 21 | 358 | 22.00 | 0 | 1 | 1.13935 | 0.16 |
315 | 357 | 4wua (A) | 613 | 655 | 42.00 | 0 | 0.82 | 0.759381 | -1.68 |
315 | 357 | 3f3z (A) | 242 | 284 | 30.00 | 0 | 0.63 | 0.620381 | -1.68 |
320 | 357 | 2x7g (A) | 662 | 699 | 50.00 | 0.012 | 0.87 | 0.812677 | -1.39 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_145294)
Species | Accession | Gene Product |
---|---|---|
Neospora caninum | NCLIV_023380 | protein kinase, PfPK7 homolog, putative |
Plasmodium berghei | PBANKA_0310300 | protein kinase 7 |
Plasmodium falciparum | PF3D7_0213400 | protein kinase 7 |
Plasmodium knowlesi | PKNH_0407600 | protein kinase 7, putative |
Plasmodium yoelii | PY02983 | Ser/Thr protein kinase |
Toxoplasma gondii | TGME49_281430 | protein kinase, putative |
Theileria parva | TP02_0630 | serine/threonine protein kinase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
PBANKA_0310300 | Plasmodium berghei | Essential | plasmo |
TGME49_281430 | Toxoplasma gondii | Essentiality uncertain | sidik |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Plasmodium falciparum | protein kinase 7 | Compounds | References |
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Patiria pectinifera | Cdc2 | 300 aa | 24.1% | 307 aa | Compounds | References |
Zea mays | Casein kinase II alpha | 332 aa | 22.6% | 270 aa | Compounds | References |
Plasmodium falciparum (isolate 3D7) | Cell division control protein 2 homolog | 288 aa | 25.0% | 360 aa | Compounds | References |
Homo sapiens | Cyclin-dependent kinase 1/cyclin B1 | 297 aa | 22.4% | 303 aa | Compounds | References |
Schizosaccharomyces pombe 972h- | Casein kinase II subunit alpha | 332 aa | 21.6% | 268 aa | Compounds | References |